Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | UVSP | HFWA |
|---|---|---|
| Price | $40.89 | $27.24 |
| Change today | ▼ 1.16% | ▼ 1.63% |
| Market cap | $1.13B | $1.11B |
| Return, 3 months | -6.2% | -5.9% |
| Return, year to date | +27.1% | +18.2% |
| Return, 1 year | +40.5% | +18.4% |
| P/E (TTM) | 11.8 | 13.0 |
| P/B | 1.2 | 1.0 |
| P/E percentile vs own 5y | 86th | 48th |
| Dividend yield | 2.18% | 3.52% |
| Revenue growth (YoY, latest qtr) | +4.1% | +48.9% |
| Net profit growth (YoY) | +14.9% | +43.6% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | 29.0% | 26.5% |
| Return on equity | 10.5% | 7.8% |
| Analyst target vs. price | +14.9% | +20.2% |
| Analyst buy share | 0% | 50% |
| RSI (14) | 38 | 35 |
| 30-day volatility | 12.2% | 15.5% |
| Max drawdown, 1 year | -9.1% | -13.0% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
